Advertisement Pharmadule Signs Contract With Sicor Biotech - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pharmadule Signs Contract With Sicor Biotech

Pharmadule, a provider of high-tech modular facilities for the pharma and biopharma industries, has signed a contract with Sicor Biotech for the delivery of a modular production facility.

Pharmadule’s scope comprises design, fabrication, installation and validation of a complete biotech production facility.

Pharmadule said that its modular concept allows 80% of the construction to be completed in its workshop resulting in a very high and predictable quality, a short delivery schedule and financial benefits for the customers.

The facility is expected to be delivered to Sicor Biotech’s site for installation, qualification and hand over to the client by January, 2011. It will be delivered according to EU and US quality standards, and is the second complete Biotech Facility delivered by Pharmadule to Sicor Biotech.